Home

DataTrends Publications, Inc.

About Us

Publications

Legal

Privacy

DERG

Home



		DERG Releases Investor's Corporate Profile® of Athersys, Inc. Comprehensive PDF report is available for download.

		Stem Cell Research News publishes "Guide to Stem Cell Companies - 10th Edition" (June 2009) Detailed information on 99 companies. Delivers the global corporate information you need to invest intelligently, stay competitive, find potential strategic partners, drive successful sales and marketing programs. See the big picture immediately by uncovering patterns, trends and relationships.

to

DataTrends

Publications, Inc.

Founded in 1987, DataTrends Publications, Inc., provides in-depth, authoritative, up-to-the-minute news analysis for managerial professionals in Cell Therapy/Regenerative Medicine and Information Technology.

Newsletters are independent and subscription-based.

For IT professionals, we publish The Report on IBM (biweekly) and Systems & Network Management Journal (biweekly).

For healthcare/medical research professionals, we publish Stem Cell Research News (biweekly), Stem Cell Business News (biweekly), Stem Cell Lab World (monthly) and Gene Therapy Research News.

Site licenses are available for each of our publications.

The DataTrends Equity Research Group, a unit of DataTrends Publications, provides independent research to small, growth-oriented public companies. DERG’s Investor’s Corporate Profile® is a comprehensive, detailed summary of a company’s business and growth strategies, history, financial data, leadership, science & technology, commercial products and products in the pipeline, markets, competition, patent portfolio and other intellectual property, strategic alliances, and risk factors.

The Profile® does not forecast the market or provide target stock prices, and does not recommend buys, sells, or holds.

For more information on the Investor's Corporate Profile®, click here.